Abgenix to Host Conference Call on Fourth Quarter and Full Year 2003 Financial Results
Tuesday February 17, 8:55 am ET
FREMONT, Calif.--(BUSINESS WIRE)--Feb. 17, 2004--Abgenix, Inc. (Nasdaq:ABGX - News) will hold a conference call on Tuesday, February 24, 2004 at 4:30 pm ET, 1:30 pm PT, to discuss fourth quarter and year end 2003 financial results. The call will be hosted by Raymond Withy, Ph.D., president and chief executive officer of Abgenix.
To participate in the teleconference, please call (800) 901-5231 fifteen minutes before the conference begins. International callers should dial (617) 786-2961. Participant pass code is 66470202. The call will also be webcast live at www.abgenix.com. A replay of the call will be available until March 9, 2004 on the company's website or by dialing (888) 286-8010. Replay participant code is 92816174.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at www.abgenix.com. |
